Cover Image
市場調查報告書

Acacia Pharma Ltd. : 產品平台檢討

Acacia Pharma Ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 224699
出版日期 內容資訊 英文 27 Pages
訂單完成後即時交付
價格
Back to Top
Acacia Pharma Ltd. : 產品平台檢討 Acacia Pharma Ltd. - Product Pipeline Review - 2015
出版日期: 2015年03月11日 內容資訊: 英文 27 Pages
簡介

Acacia Pharma Ltd. ,是開發術後及癌症患者的支持療法產品的製藥公司。該公司的產品主要用於防止術後的噁心嘔吐。

本報告提供Acacia Pharma Ltd. 的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的、作用機制、給藥途徑、分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

Acacia Pharma Ltd.的基本資料

  • Acacia Pharma Ltd.概要
  • 主要資訊
  • 企業資料

Acacia Pharma Ltd. :R&D概要

  • 主要的治療範圍

Acacia Pharma Ltd. :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品
  • 聯合治療模式

Acacia Pharma Ltd. :開發中產品概況

  • 最後階段的開發中產品
    • 第三階段的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式

Acacia Pharma Ltd. :藥物簡介

  • APD-421
  • (formoterol fumarate + megestrol acetate)
  • APD-403
  • APD-515

Acacia Pharma Ltd. :開發平台分析

  • 各標靶
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Acacia Pharma Ltd. :最近的開發平台趨勢

Acacia Pharma Ltd. :暫停中的計劃

Acacia Pharma Ltd. :開發中止的開發中產品

  • 開發中止的開發中產品簡介
    • APD-405

Acacia Pharma Ltd. :總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06845CDB

Summary

Global Markets Direct's, 'Acacia Pharma Ltd. - Product Pipeline Review - 2015', provides an overview of the Acacia Pharma Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Acacia Pharma Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Acacia Pharma Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Acacia Pharma Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Acacia Pharma Ltd.'s pipeline products

Reasons to buy

  • Evaluate Acacia Pharma Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Acacia Pharma Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Acacia Pharma Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Acacia Pharma Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Acacia Pharma Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Acacia Pharma Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Acacia Pharma Ltd. Snapshot
    • Acacia Pharma Ltd. Overview
    • Key Information
    • Key Facts
  • Acacia Pharma Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Acacia Pharma Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
  • Acacia Pharma Ltd. - Pipeline Products Glance
    • Acacia Pharma Ltd. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Acacia Pharma Ltd. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
  • Acacia Pharma Ltd. - Drug Profiles
    • APD-421
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • (formoterol fumarate + megestrol acetate)
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • APD-403
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • APD-515
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Acacia Pharma Ltd. - Pipeline Analysis
    • Acacia Pharma Ltd. - Pipeline Products by Target
    • Acacia Pharma Ltd. - Pipeline Products by Route of Administration
    • Acacia Pharma Ltd. - Pipeline Products by Molecule Type
    • Acacia Pharma Ltd. - Pipeline Products by Mechanism of Action
  • Acacia Pharma Ltd. - Recent Pipeline Updates
  • Acacia Pharma Ltd. - Dormant Projects
  • Acacia Pharma Ltd. - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • APD-405
  • Acacia Pharma Ltd. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Acacia Pharma Ltd., Key Information
  • Acacia Pharma Ltd., Key Facts
  • Acacia Pharma Ltd. - Pipeline by Indication, 2015
  • Acacia Pharma Ltd. - Pipeline by Stage of Development, 2015
  • Acacia Pharma Ltd. - Monotherapy Products in Pipeline, 2015
  • Acacia Pharma Ltd. - Combination Treatment Modalities in Pipeline, 2015
  • Acacia Pharma Ltd. - Phase III, 2015
  • Acacia Pharma Ltd. - Phase II, 2015
  • Acacia Pharma Ltd. - Pipeline by Target, 2015
  • Acacia Pharma Ltd. - Pipeline by Route of Administration, 2015
  • Acacia Pharma Ltd. - Pipeline by Molecule Type, 2015
  • Acacia Pharma Ltd. - Pipeline Products by Mechanism of Action, 2015
  • Acacia Pharma Ltd. - Recent Pipeline Updates, 2015
  • Acacia Pharma Ltd. - Dormant Developmental Projects,2015
  • Acacia Pharma Ltd. - Discontinued Pipeline Products, 2015

List of Figures

  • Acacia Pharma Ltd. - Pipeline by Top 10 Indication, 2015
  • Acacia Pharma Ltd. - Pipeline by Stage of Development, 2015
  • Acacia Pharma Ltd. - Monotherapy Products in Pipeline, 2015
  • Acacia Pharma Ltd. - Pipeline by Top 10 Target, 2015
  • Acacia Pharma Ltd. - Pipeline by Top 10 Route of Administration, 2015
  • Acacia Pharma Ltd. - Pipeline by Top 10 Molecule Type, 2015
  • Acacia Pharma Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top